Trials / Completed
CompletedNCT00898170
Effect of Myoma Removal on Blood Pressure and Erythropoetin Level
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 28 (actual)
- Sponsor
- Shiraz University of Medical Sciences · Academic / Other
- Sex
- Female
- Age
- 22 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
The effect of myoma removal was studied on 28 patients with hypertension and myoma by holter monitoring and erythropoetin level check.
Detailed description
Background: Myoma is the most common gynecoid tumor and produces many vasoactive substances, which may be a cause for secondary hypertension. Early reports suggested the association of myoma and hypertension. We studied the effect of myoma removal on hypertension and erythropoietin level to evaluate this hypothesis. Patients \& Methods: In this single centered prospective cohort study, in twenty eight patients who were candidates for myomectomy due to myoma, 24 hour holter monitoring of blood pressure and serum erythropoietin were checked before and 6 weeks after hysterectomy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | myoma removal | surgical removal of myoma by hysterectomy |
Timeline
- Start date
- 2008-05-01
- Primary completion
- 2009-03-01
- Completion
- 2009-03-01
- First posted
- 2009-05-12
- Last updated
- 2009-05-12
Locations
1 site across 1 country: Iran
Source: ClinicalTrials.gov record NCT00898170. Inclusion in this directory is not an endorsement.